Li-Li Huang Selected Research

Membrane Fusion Proteins

12/2019

Augmenter of Liver Regeneration Alleviates Renal Hypoxia-Reoxygenation Injury by Regulating Mitochondrial Dynamics in Renal Tubular Epithelial Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Li-Li Huang Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 12/2006
4	Insulin Resistance 01/2021 - 07/2014
4	Cicatrix (Scar) 11/2017 - 12/2013
3	Lung Neoplasms (Lung Cancer) 07/2022 - 12/2006
3	Inflammation (Inflammations) 01/2022 - 12/2010
3	Hypoxia (Hypoxemia) 01/2022 - 12/2018
3	Pregnancy Complications 01/2020 - 03/2018
3	Wounds and Injuries (Trauma) 02/2019 - 02/2007
3	Uterine Hemorrhage (Uterine Bleeding) 11/2015 - 12/2013
2	Body Weight (Weight, Body) 01/2021 - 02/2018
2	Obesity 01/2021 - 02/2018
2	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 01/2021
2	Hemorrhage 03/2020 - 12/2013
2	Acute Lung Injury 10/2019 - 10/2018
2	Traumatic Brain Injuries (Traumatic Brain Injury) 02/2019 - 12/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 12/2006
2	Birth Weight (Birth Weights) 02/2018 - 01/2017
2	Atherosclerosis 08/2016 - 12/2010
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2015 - 07/2014
2	Neoplasm Metastasis (Metastasis) 08/2011 - 12/2006
1	COVID-19 01/2022
1	Opportunistic Infections (Opportunistic Infection) 07/2021
1	Tuberculosis (Tuberculoses) 07/2021
1	Reperfusion Injury 01/2021
1	Hyperglycemia 01/2021
1	Hyperlipidemias (Hyperlipidemia) 01/2021
1	Transient Ischemic Attack 03/2020
1	Stroke (Strokes) 03/2020
1	Ischemia 03/2020
1	Myocardial Infarction 03/2020
1	Hematoma 03/2020
1	Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy) 12/2019
1	Mycoses (Diseases, Fungus) 08/2019
1	Fever (Fevers) 08/2019
1	Astigmatism 01/2019
1	Cataract (Cataracts) 01/2019
1	Neuroinflammatory Diseases 12/2018
1	Glucose Metabolism Disorders 10/2018
1	Glucose Intolerance 10/2018
1	Emaciation 02/2018
1	Overweight 02/2018

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2011
4	AntigensIBA 01/2022 - 01/2015
3	Pharmaceutical PreparationsIBA 08/2019 - 02/2010
2	Blood Glucose (Blood Sugar)IBA 01/2021 - 10/2018
2	CholesterolIBA 01/2021 - 09/2016
2	Insulin (Novolin)FDA Link 01/2021 - 10/2018
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 09/2016
2	isoliquiritigenin (GU 17)IBA 02/2019 - 12/2018
2	Fatty Acids (Saturated Fatty Acids)IBA 07/2014 - 12/2012
2	Cisplatin (Platino)FDA LinkGeneric 12/2010 - 02/2010
1	CurcuminIBA 07/2022
1	Cancer VaccinesIBA 01/2022
1	Monocyte Chemoattractant ProteinsIBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 07/2021
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 02/2021
1	HDL LipoproteinsIBA 01/2021
1	fucoxanthinIBA 01/2021
1	oxidized low density lipoproteinIBA 01/2021
1	pachymic acidIBA 01/2021
1	Ringer's LactateIBA 01/2021
1	Saline SolutionIBA 01/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	ProdrugsIBA 01/2020
1	discoidin-binding polysaccharideIBA 01/2020
1	Dynamins (Dynamin)IBA 12/2019
1	Membrane Fusion ProteinsIBA 12/2019
1	Oxygen (Dioxygen)IBA 11/2019
1	InflammasomesIBA 10/2019
1	Caspofungin (Cancidas)FDA Link 08/2019
1	Transferrin Receptors (Transferrin Receptor)IBA 02/2019
1	Small Interfering RNA (siRNA)IBA 12/2018
1	Aromatase (CYP19)IBA 10/2018
1	LipopolysaccharidesIBA 10/2018
1	Gonadal Steroid Hormones (Sex Hormones)IBA 10/2018
1	Type 2 Angiotensin ReceptorIBA 10/2018
1	phthalic acid (phthalate)IBA 09/2018
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 03/2018
1	GhrelinIBA 02/2018
1	AdiponectinIBA 02/2018
1	LeptinIBA 02/2018
1	IntegrinsIBA 11/2017

Therapy/Procedure

7	Therapeutics 07/2021 - 01/2015
3	Immunotherapy 01/2022 - 01/2020
2	Drug Therapy (Chemotherapy) 02/2021 - 02/2010
2	Aftercare (After-Treatment) 01/2021 - 08/2011
2	Length of Stay 03/2020 - 03/2020
2	Cesarean Section (Caesarean Section) 11/2017 - 07/2017
2	Curettage 07/2017 - 11/2015
2	Hysterectomy 11/2015 - 07/2014
2	Uterine Artery Embolization 11/2015 - 12/2013
1	Liver Transplantation 01/2021
1	Retreatment 03/2020
1	Oncolytic Virotherapy 02/2019
1	Phacoemulsification 01/2019
1	Activities of Daily Living (ADL) 12/2018
1	Transplantation 10/2018
1	Pessaries 01/2017